Pharmafile Logo
Pharmafocus logo
Advanced Search

tivozanib

Showing 4 posts of 4 posts found.

Scotland approves first-line treatment for advanced kidney cancer

July 9, 2018
Sales and Marketing Cancer, Scotland, fotivda, rcc, tivozanib

The Scottish Medicines Consortium has approved the use of EUSA Pharma’s Fotivda (tivozanib) as a first-line treatment for people with …

News

Aveo and Astellas part ways

February 17, 2014
Sales and Marketing Astellas, Aveo, Boehringer, EMA, tivozanib

Aveo Oncology and Astellas Pharma are to abandon their three-year old collaboration and licence agreement for investigational tyrosine kinase inhibitor …

News

Aveo to cut workforce after FDA knock-back

June 6, 2013
Research and Development, Sales and Marketing Aveo, FDA, cuts, tivozanib

Aveo will make major jobs cuts this year after news that a kidney cancer licence for its oncology drug tivozanib …

News

Astellas to commercialise new kidney cancer drug in Europe

February 21, 2011
Sales and Marketing Astellas, Aveo Pharmaceuticals, Cancer, Kidney cancer, rcc, renal cell carcinoma, tivozanib

Astellas and Aveo Pharmaceuticals are to commercialise Aveo’s investigational kidney cancer drug tivozanib in Europe and the US. Aveo is …

News

Latest content

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024

Fulcrum Therapeutics and Sanofi enter collaboration for facioscapulohumeral muscular dystrophy treatment

May 14, 2024

PharmaTimes Medical & Scientific Excellence Awards and Nursing Industry Excellence Awards are open for entry

May 13, 2024

Sanofi adds €1bn funding for biomanufacturing projects in France

May 13, 2024

Moderna shares update on RSV vaccine

May 13, 2024